Document Detail


Successful treatment with rituximab of refractory idiopathic thrombocytopenic purpura in a patient with Kabuki syndrome.
MedLine Citation:
PMID:  19662467     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Kabuki syndrome (KS) is often associated with autoimmune abnormalities, such as idiopathic thrombocytopenic purpura (ITP), autoimmune hemolytic anemia, leukoplakia and thyroiditis, as well as congenital anomalies. We herein present a KS patient with refractory ITP who achieved durable and complete remission in response to a total of four once-monthly infusions of rituximab. KS patients are often more susceptible to infection, so splenectomy should be avoided. Therefore, rituximab therapy is an alternative option for KS patients with ITP who fail to respond to first-line therapy.
Authors:
Yuka Torii; Hiroshi Yagasaki; Hidenori Tanaka; Seiji Mizuno; Nobuhiro Nishio; Hideki Muramatsu; Asahito Hama; Yoshiyuki Takahashi; Seiji Kojima
Related Documents :
2780017 - Episodic supersalivation (idiopathic paroxysmal sialorrhea): description of a new clini...
5412947 - Hypocalcaemic primary hyperparathyroidism.
3982067 - Mitral valve replacement in idiopathic hypereosinophilic syndrome.
6881247 - The familial occurrence of cutaneous melanoma, intraocular melanoma, and the dysplastic...
18000967 - The face of joubert syndrome: a study of dysmorphology and anthropometry.
12503107 - Hypertrichosis terminalis, gingival hyperplasia, and a characteristic face: a new disti...
Publication Detail:
Type:  Case Reports; Journal Article     Date:  2009-08-07
Journal Detail:
Title:  International journal of hematology     Volume:  90     ISSN:  1865-3774     ISO Abbreviation:  Int. J. Hematol.     Publication Date:  2009 Sep 
Date Detail:
Created Date:  2009-08-24     Completed Date:  2009-11-12     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9111627     Medline TA:  Int J Hematol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  174-6     Citation Subset:  IM    
Affiliation:
Department of Pediatrics, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Abnormalities, Multiple / blood,  immunology*
Antibodies, Monoclonal / administration & dosage*
Child, Preschool
Humans
Immunologic Factors / administration & dosage*
Male
Platelet Count
Purpura, Thrombocytopenic, Idiopathic / drug therapy*,  immunology*
Syndrome
Chemical
Reg. No./Substance:
0/Antibodies, Monoclonal; 0/Immunologic Factors; 0/rituximab

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Dual molecular imaging for targeting metalloproteinase activity and apoptosis in atherosclerosis: mo...
Next Document:  Difference in evaluation of patients with low back pain using the Japanese Orthopaedic Association S...